high-risk solid tumors
Showing 1 - 25 of >10,000
Solid Tumor Trial in Washington (Tumor-associated antigen-specific T cell (TAA-T))
Recruiting
- Solid Tumor
- Tumor-associated antigen-specific T cell (TAA-T)
-
Washington, District of ColumbiaChildren's National Hospital
Oct 24, 2022
Lymphocytes, Tumor-Infiltrating Trial in Saint Petersburg (Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide,
Not yet recruiting
- Lymphocytes
- Tumor-Infiltrating
- Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide, Interleukin-2
-
Saint Petersburg, Florida
- +1 more
Sep 15, 2023
Neuroblastoma, CNS Tumor, Sarcoma Trial in Columbus (Cabozantinib)
Recruiting
- Neuroblastoma
- +2 more
-
Columbus, OhioNationwide Children's Hospital
Dec 20, 2022
Refractory and/or Relapsed Metastatic Solid Tumors Trial in United States (Cyclophosphamide, Fludarabine, low dose total body
Recruiting
- Refractory and/or Relapsed Metastatic Solid Tumors
- Cyclophosphamide
- +4 more
-
Saint Petersburg, Florida
- +4 more
Oct 29, 2021
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma Trial in Madison (TCRaß+/CD19+ depleted Haploidentical
Recruiting
- Acute Myeloid Leukemia
- +10 more
- TCRαβ+/CD19+ depleted Haploidentical HSCT
- Zoledronate
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Mar 1, 2022
Malignant Solid Tumor Trial in Nashville (Ifetroban Sodium, Placebo)
Recruiting
- Malignant Solid Tumor
- Ifetroban Sodium
- Placebo
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Jun 23, 2022
Solid Tumors, Brain Tumors Trial in Cincinnati (Amifostine)
Terminated
- Solid Tumors
- Brain Tumors
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Dec 29, 2021
Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small
Recruiting
- Desmoplastic Small Round Cell Tumor
- +11 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Jun 26, 2022
Neuroblastoma, Neuroblastoma Recurrent, GD2-positive Solid Tumors Trial in Roma (GD2-CART01)
Recruiting
- Neuroblastoma
- +5 more
- GD2-CART01
-
Roma, ItalyOspedale Pediatrico Bambino Gesù
Mar 9, 2022
Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)
Recruiting
- Ewing's Family Tumors
- +11 more
- Ifosfamide
- +13 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Apr 11, 2022
Brain Cancer, Glioma Trial in New York (MRI and advanced MRI sequences)
Recruiting
- Brain Cancer
- Glioma
- MRI and advanced MRI sequences
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Sep 1, 2021
Neuroblastoma Trial in New York (3F8 Monoclonal Antibody Combined with Interleukin-2)
Completed
- Neuroblastoma
- 3F8 Monoclonal Antibody Combined with Interleukin-2
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 26, 2021
Metastatic Solid Tumors of Metastatic Disease Trial in United States (Radiation Therapy, Systemic Therapy)
Recruiting
- Metastatic Solid Tumors of Metastatic Disease
- Radiation Therapy
- Systemic Therapy
-
Miami, Florida
- +8 more
Dec 6, 2022
Right-sided Hemicolectomy for Chldren With High-risk
Recruiting
- Neoplasms
- Appendix Cancer
-
Amsterdam-Zuidoost, NetherlandsAmsterdam UMC
Jun 23, 2023
Chemotherapy Solid Tumors Who Receiving Thrombocytopenia
Completed
- Chemotherapy-induced Thrombocytopenia
- Recombinant Human Interleukin-11 for Injection
-
Shenyang, Liaoning, ChinaXing Xiaojing
Jan 15, 2023
Melanoma, Hepatocellular Carcinoma (HCC), Renal Cell Carcinoma (RCC) Trial (INCB 99280 with Ipilimumab)
Not yet recruiting
- Melanoma
- +5 more
- INCB 99280 with Ipilimumab
- (no location specified)
Jun 9, 2023
CNS Tumor, Solid Tumor Trial in Worldwide (Nivolumab and Entinostat)
Recruiting
- CNS Tumor
- Solid Tumor
- Nivolumab and Entinostat
-
Randwick, New South Wales, Australia
- +13 more
Nov 8, 2022
Solid Tumor, Unspecified, Adult Trial in Meldola (68 Gallium -Fibroblast Activating Protein Inhibitor -46 Positron emission
Recruiting
- Solid Tumor, Unspecified, Adult
- 68 Gallium -Fibroblast Activating Protein Inhibitor -46 Positron emission tomography / Computerized tomography
-
Meldola, Forlì Cesena, ItalyIRCCS Istituto ROmagnolo per lo Studio dei Tumori "Dino Amadori"
Nov 15, 2023
Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)
Completed
- Pancreatic Neuroendocrine Tumor G2
- Octreotide LAR
- (no location specified)
Oct 17, 2023
Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD
Recruiting
- Gastrointestinal Stromal Tumors
- Minimal Residual Disease
- liquid biopsy
-
Beijing, Beijing, ChinaPeking University People'S Hospital
Sep 18, 2022
High-grade Glioma, Solid Tumor, Unspecified, Child Trial in Edison (2-OHOA)
Recruiting
- High-grade Glioma
- Solid Tumor, Unspecified, Child
-
Edison, New JerseyHackensack Meridian Health, Inc
Aug 16, 2022
Clinical Research of Drug Holiday Based on MRD Detection in GIST
Recruiting
- Gastrointestinal Stromal Tumors
-
Beijing, Beijing, ChinaPeking University People's Hospital
May 11, 2023